Ophthalmic devices, such as contact lenses, may incorporate myopia control optics in combination with therapeutic agents also known to control myopia to create a drug delivery mechanism to inhibit or arrest the progression of myopia in individuals. Any number of contact lenses incorporating myopia control optics may be combined with a therapeutic agent such as atropine, atropine sulphate monohydrate, and/or pirenzepine眼用裝置，例如隱形眼鏡可以併入近視控制光學元件，並與習知亦可控制近視的治療劑結合，以形成藥物輸送機制來抑制或阻止個人的近視加深。可以將任何數量併入近視控制光學元件的隱形眼鏡與治療劑結合，該治療劑例如阿托品、阿托品硫酸鹽單水合物及/或哌崙西平。
